# Ramelteon

NDC: 42291-776
Generic name: Ramelteon
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201221

FDA application: ANDA213186

## Active ingredients

- RAMELTEON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42291-776"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42291-776
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6fc0db5-c68f-5af9-e053-2a95a90a5110